Market News AIOpen the app

ATOS stock news · Atossa Therapeutics, Inc.

Stories about Atossa Therapeutics, Inc. (ATOS) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for ATOS

Follow Atossa Therapeutics, Inc. (ATOS) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for ATOS
Free on the App Store and Google Play, or on the web.
  1. Nov 10, 2026, 9:07 AM ET · Market

    Atossa Therapeutics shared its financial results for the third quarter of 2026, showing progress with its drug programs.

    Neutral

    Atossa reported third-quarter results, but the supplied text gives no figures or specific pipeline changes. It does not show a clear change in the company's outlook.

  2. Oct 9, 2026, 8:24 AM ET · Market

    Atossa Therapeutics, Inc. has signed an important agreement involving special rights for its stock.

    Neutral

    Atossa attached a conditional voucher-payment right to each share. No voucher exists yet, so this changes who may receive future proceeds, not the company's drug progress.

  3. Sep 18, 2026, 5:08 PM ET · Market

    Atossa Therapeutics, Inc. shared an updated company presentation with the SEC.

    Neutral

    Atossa posted an updated corporate presentation via an 8-K; this disclosure does not change the company's business or finances.